M

MesenFlow Technologies SARL

3 employees

MesenFlow Technologies has developed a platform to meet the demands of modern drug development.

Basic info

Industry

biotechnology research

Sectors

In-vitro testing
Drug repurposing
Clinical samples
Translational medicine
Human cells
Animal-free
Fee-per-service
In-vitro pharmacology
Health Care
Oncology
Bio-imaging
Pharmaceuticals
Toxicity
Organoid
Drug Development
Drug discovery
Proof-of-concept
Inflammation
Medical
Disease modelling
accelerated drug development
Preclinical drug development

Date founded

2016

Funding rounds raised

Total raised

$10K

from 1 investors over 1 rounds

M

MesenFlow Technologies SARL raised $10K on April 25, 2017

Investors: Venture Kick

FAQ